PDL BioPharma, Inc. Long-Term Debt, Maturity, Year Two
PDL BioPharma, Inc. had Long-Term Debt, Maturity, Year Two of $0 as of 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2021-03-29
- 2020-12-31: Long-Term Debt, Maturity, Year Two $0.00.
- 2019-12-31: Long-Term Debt, Maturity, Year Two $19.17M.
- 2018-12-31: Long-Term Debt, Maturity, Year Two $0.00.
- 2017-12-31: Long-Term Debt, Maturity, Year Two $0.00.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-29 |
| 2019-12-31 | $19.17M 8-K · filed 2020-06-29 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-15 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-16 |
| 2016-12-31 | $126.45M 10-K · filed 2017-03-01 |
| 2015-12-31 | $0.00 10-K · filed 2016-02-23 |
| 2014-12-31 | $300.00M 10-K · filed 2015-02-23 |
| 2013-12-31 | $335.25M 10-K · filed 2014-03-03 |
| 2012-12-31 | $0.00 10-K · filed 2013-03-01 |
| 2011-12-31 | $0.00 10-K · filed 2012-02-23 |